Pertussis vaccination responses in COPD patients

FHS
July 21, 2023
10:27 am

Researchers evaluated the humoral and cellular immune responses to pertussis vaccination in COPD patients.

Philips consent decree ‘worse case scenario’ for respiratory business

Philips’ U.S. sleep and respiratory care business could be set back by years as it now faces a consent decree from the Food and Drug

February 6, 2024

ABBV-400 by AbbVie for Metastatic Hepatocellular Carcinoma (HCC): Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 21, 2023

Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 05.03.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

March 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.